论文部分内容阅读
目的观察中西药联合治疗支气管哮喘的临床效果。方法将98例支气管哮喘患者随机分为治疗组和对照组各49例。对照组采用单纯西药治疗,治疗组在对照组基础上加用中药治疗。对比2组临床疗效、免疫学效果。结果治疗组的总有效率为93.88%高于对照组的83.67%,差异有统计学意义(P<0.05);治疗后,2组CD+3、重组人干扰素-γ(IFN-g)水平及IFN-g/IL-4比值升高,IL-4水平降低,且治疗组变化幅度大于对照组,差异均有统计学意义(P<0.05)。结论中西药联合治疗支气管哮喘疗效较好,可提高患者的免疫功能,值得临床推广应用。
Objective To observe the clinical effect of combining traditional Chinese and western medicine on bronchial asthma. Methods 98 patients with bronchial asthma were randomly divided into treatment group and control group, 49 cases each. The control group was treated with western medicine alone, and the treatment group was treated with traditional Chinese medicine on the basis of the control group. The clinical efficacy and immunological effects of two groups were compared. Results The total effective rate of the treatment group was 93.88%, which was significantly higher than that of the control group (83.67%, P <0.05). After treatment, the levels of CD + 3, IFN-g And the ratio of IFN-g / IL-4 increased, the level of IL-4 decreased, and the change range of the treatment group was greater than that of the control group, the difference was statistically significant (P <0.05). Conclusion The combined treatment of traditional Chinese and western medicine is effective in treating bronchial asthma, which can improve the immune function of patients and is worthy of clinical application.